12:00 AM
 | 
Feb 09, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Bioral Amphotericin B: Phase I data

In a placebo-controlled, U.S. Phase I trial in 48 healthy volunteers, Bioral was well tolerated without meaningful changes in laboratory safety values including...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >